Coagulation Defect

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
20'Whole Blood ClottingTestN/A1 trial
Active Trials
NCT03890016Completed230Est. Jun 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Mission Therapeutics20'Whole Blood ClottingTest

Clinical Trials (1)

Total enrollment: 230 patients across 1 trials

NCT03890016Mission Therapeutics20'Whole Blood ClottingTest

Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims

Start: May 2019Est. completion: Jun 2020230 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space